Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New methods in lipid research]

G Luc1, J C Fruchart

  • 1SERLIA-INSERM U325, Institut Pasteur de Lille.

Presse Medicale (Paris, France : 1983)
|October 15, 1994
PubMed
Summary
This summary is machine-generated.

Arteriosclerosis risk is assessed by evaluating lipid levels, including high-density lipoproteins (HDL) and low-density lipoproteins (LDL). New lipoprotein subfractions like Lipoprotein A1 (LpAI) and Lp(a) offer further insights for managing cardiovascular disease risk.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.

Neurogastroenterology and motility·2015
Same author

Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects.

Atherosclerosis·2014
Same author

Management of large para-esophageal hiatal hernias.

Journal of visceral surgery·2013
Same author

Primary monophasic synovial sarcoma of the pancreas.

Journal of visceral surgery·2013
Same author

Re-operation for failed gastro-esophageal fundoplication. What results to expect?

Journal of visceral surgery·2012
Same author

Systemic chemokine levels, coronary heart disease, and ischemic stroke events: the PRIME study.

Neurology·2011
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Preventive Cardiology

Context:

  • Arteriosclerosis, a multifactorial disease, is primarily managed through prevention.
  • Abnormal lipoproteins are key risk factors for arteriosclerosis and coronary artery disease.
  • Lipid-related risk factors require a stepwise evaluation process.

Purpose:

  • To outline the stepwise evaluation of lipid-related risk factors for arteriosclerosis.
  • To discuss the role of high-density lipoproteins (HDL) and low-density lipoproteins (LDL) in risk assessment.
  • To explore the emerging importance of lipoprotein subfractions like LpAI and Lp(a) in clinical practice.

Summary:

  • Initial screening involves fasting blood cholesterol and triglyceride levels.
  • Further classification may utilize HDL and calculated LDL cholesterol levels.

Related Experiment Videos

  • Lipoprotein A1 (LpAI) and Lp(a) provide crucial, routine information for assessing arteriosclerosis risk and guiding therapeutic decisions.

    • Impact:

    • Standard lipid profiles are essential for initial risk stratification.
    • Lipoprotein subfractions LpAI and Lp(a) offer enhanced diagnostic value for cardiovascular risk.
    • Future research into genetic markers may further refine arteriosclerosis risk prediction and management.